Biotin-Kinase Domain of Insulin Receptor (5)
CAS No. ———
Biotin-Kinase Domain of Insulin Receptor (5)( ——— )
Catalog No. M41567 CAS No. ———
Biotin-Kinase Domain of Insulin Receptor (5)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameBiotin-Kinase Domain of Insulin Receptor (5)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBiotin-Kinase Domain of Insulin Receptor (5)
-
DescriptionBiotin-Kinase Domain of Insulin Receptor (5)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight2089.07
-
Molecular FormulaC82H124N21O35S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PTD-p65-P1 Peptide
PTD-p65-P1 Peptide is a nuclear transcription factor NF-kappaB inhibitor, composed of a membrane-translocating peptide sequence generated from antennapedia (PTD) conjugated with p65-P1, which selectively inhibits activation induced by various inflammatory stimuli. PTD-p65-P1 suppressed NF-kappaB activation induced by lipopolysaccharide, interleukin-1, okadaic acid, phorbol 12-myristate 13-acetate, H(2)O(2), and cigarette smoke condensate as well as that induced by TNF.
-
6-Acryloyloxyhexyl p...
6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.
-
N-Benzylstearamide
N-Benzyloctadecanamide is a distinct class of secondary metabolites in Lepidium meyenii Walp. (Maca).
Cart
sales@molnova.com